Back to IKT

UBS Group AG → IKT

UBS Group AG IKT Position History

Inhibikase Therapeutics, Inc. • Healthcare

Quarters held
8
Latest value
$1.3M
Q3 2026
Peak value
$1.3M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$221K
Q3 2025$168
Q4 2025$187K
Q4 2025$7K
Q1 2026$362K
Q1 2026$21K
Q2 2026$415K
Q3 2026$1.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.3M621.6K——
Q2 2026$415K204.7K——
Q1 2026$21K12.5K——
Q1 2026$362K215.7K——
Q4 2025$7K3.5K——
Q4 2025$187K91.1K——
Q3 2025$168104——
Q3 2025$221K136.2K——

Other funds holding IKT

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B